The UC Berkeley-linked cell biology technology provider has raised about $215m in venture funding.
Berkeley Lights, a US-based digital cell biology developer based on research at University of California, Berkeley, has filed to raise up to $100m in an initial public offering that would enable corporates Nikon and Varian Medical Systems to exit.
Founded in 2011, Berkeley Lights has created technology that captures single-cell specific information to support the development of cell-based products including antibody therapeutics or cell therapies.
The company made an $18.3m net loss in 2019 from $56.7m in…
